Notice of Lodging of Proposed Consent Decree Under the Clean Air Act, 23625-23626 [2011-10052]
Download as PDF
<![CDATA[
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
Federal Register / Vol. 76, No. 81 / Wednesday, April 27, 2011 / Notices
9607. The proposed Consent Decree
would resolve claims that the United
States has asserted against all
defendants.
Under the proposed Consent Decree,
a group of four ‘‘Performing Settling
Defendants’’ will implement remedial
measures at the Site consistent with an
Explanation of Significant Differences
issued by the United States
Environmental Protection Agency (‘‘U.S.
EPA’’) on September 13, 2010. These
remedial measures will include:
(1) Evaluation of potential measures to
optimize performance of the previouslyimplemented source control remedy at
the Site and implementation of any
appropriate source control remedy
enhancements; (2) development and
implementation of an Institutional
Control Implementation and Assurance
Plan; and (3) completing a three-year
evaluation of the effectiveness of
monitored natural attenuation as a
means of achieving groundwater
cleanup standards at the Site. Following
completion of the monitored natural
attenuation study, if U.S. EPA
determines that monitored natural
attenuation is not appropriate for this
Site, Performing Settling Defendants
will evaluate alternative groundwater
remedies and implement an alternative
groundwater remedy selected by EPA.
Under the proposed decree, Performing
Settling Defendants will also pay
$985,000 to the Hazardous Substances
Superfund to reimburse response costs
incurred by the United States through
January 31, 2010 in connection with the
Site, and they will reimburse all
response costs incurred by the United
States after January 31, 2010 in
connection with the Site.
The remaining 34 defendants, ‘‘De
Minimis Settling Defendants,’’ will
resolve their potential liability with
respect to the Site in accordance with
Section 122(g) of CERCLA, 42 U.S.C.
9622(g), through specified payments
that will be used by Performing Settling
Defendants to pay for costs incurred
pursuant to the Consent Decree.
The Department of Justice will receive
comments relating to the Consent
Decree for a period of thirty (30) days
from the date of this publication.
Comments should be addressed to the
Assistant Attorney General,
Environment and Natural Resources
Division, and either e-mailed to
pubcomment-ees.enrd@usdoj.gov or
mailed to P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611, and should refer to United
States v. Waste Management of
Wisconsin, Inc., et al., DJ # 90–11–3–
09747.
VerDate Mar<15>2010
15:36 Apr 26, 2011
Jkt 223001
The Consent Decree may be examined
at the Office of the United States
Attorney, Eastern District of Wisconsin,
530 Federal Building, 517 East
Wisconsin Avenue, Milwaukee, WI
53202 and at U.S. EPA Region 5, 77 W.
Jackson Blvd., Chicago, IL 60604.
During the public comment period, the
Consent Decree may also be examined
on the following Department of Justice
Web site, https://www.usdoj.gov/enrd/
Consent_ Decrees.html. A copy of the
Consent Decrees may also be obtained
by mail from the Consent Decree
Library, U.S. Department of Justice, P.O.
Box 7611, Washington, DC 20044–7611
or by faxing or e-mailing a request to
Tonia Fleetwood
(tonia.fleetwood@usdoj.gov), fax number
(202) 514–0097, phone confirmation
number (202) 514–1547. In requesting a
copy of the Consent Decree from the
Consent Decree Library, please enclose
a check in the amount of $82.00 (25
cents per page reproduction cost)
payable to the U.S. Treasury or, if by email or fax, forward a check in that
amount to the Consent Decree Library at
the stated address.
Maureen M. Katz,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division, United States
Department of Justice.
[FR Doc. 2011–10069 Filed 4–26–11; 8:45 am]
BILLING CODE 4410–15–P
23625
Attorney General, Environment and
Natural Resources Division, and either
e-mailed to pubcommentees.enrd@usdoj.gov or mailed to P.O.
Box 7611, U.S. Department of Justice,
Washington, DC 20044–7611, and
should refer to United States v. P4
Production L.L.C., No. 11–00166–REB
(D. Idaho), Department of Justice Case
Number 90–5–1–1–09868.
During the public comment period,
the Consent Decree may be examined at
the Office of the United States Attorney,
District of Idaho, 800 Park Boulevard,
Suite 600, Boise, Idaho. The Settlement
Agreement may also be examined on the
following Department of Justice Web
site, https://www.justice.gov/enrd/
Consent_Decrees.html. A copy of the
Consent Decree may also be obtained by
mail from the Consent Decree Library,
P.O. Box 7611, U.S. Department of
Justice, Washington, DC 20044–7611 or
by faxing or e-mailing a request to Tonia
Fleetwood (tonia.fleetwood@usdoj.gov),
fax no. (202) 514–0097, phone
confirmation number (202) 514–1547. In
requesting a copy from the Consent
Decree Library, please enclose a check
in the amount of $9.00 (25 cents per
page reproduction cost) payable to the
U.S. Treasury.
Robert E. Maher, Jr.,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2011–10071 Filed 4–26–11; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Notice of Filing of Consent Decree
Pursuant to the Clean Water Act
(‘‘CWA’’)
Notice is hereby given that on April
20, 2011, a proposed Consent Decree in
United States v. P4 Production L.L.C.,
No. 11–00166–REB, was lodged in the
United States District Court for the
District of Idaho. The Consent Decree
settles the United States’ claims alleged
in the Complaint pursuant to Section
309 of the Clean Water Act (CWA), 33
U.S.C. 1319. The Complaint relates to
P4’s South Rasmussen Mine, which is in
southeast Idaho about 20 miles
northeast of Soda Springs. The Consent
Decree requires payment of a civil
penalty of $1,400,000. The Consent
Decree also includes injunctive relief
which requires P4 to prevent leachate
and certain storm water from its waste
rock from discharging to the
downstream creek and wetland.
The Department of Justice will receive
comments related to the Consent Decree
for a period of thirty (30) days from the
date of this publication. Comments
should be addressed to the Assistant
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the Clean Air
Act
Notice is hereby given that on April
13, 2011, a proposed Consent Decree
was filed with the United States District
Court for the District of Oregon in
United States v. JELD–WEN, Inc., No.
3:11–cv–453–JT (D. Or.). The proposed
Consent Decree entered into by the
United States, the States of West
Virginia, Iowa, and North Carolina, and
the company resolves the United States’
and States’ claims against the company
for civil penalties and injunctive relief
pursuant to the Clean Air Act, 42 U.S.C.
7412, 7413. Under the terms of the
Consent Decree, JELD–WEN will pay the
United States and States a combined
civil penalty of $850,000, for excessive
emissions of hazardous air pollutants
from four door skin manufacturing
plants located in Washington, Iowa,
North Carolina, West Virginia. In
addition, JELD–WEN will undertake
projects to offset its excess emission,
E:\FR\FM\27APN1.SGM
27APN1
23626
Federal Register / Vol. 76, No. 81 / Wednesday, April 27, 2011 / Notices
study and install process changes or
controls to eliminate excess emissions,
and comply with interim emission
limits.
The Department of Justice will receive
comments relating to the proposed
Consent Decree for a period of thirty
(30) days from the date of this
publication. Comments should be
addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and either e-mailed
to pubcomment-ees.enrd@usdoj.gov or
mailed to P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611, and should refer to United
States v. JELD–WEN, Inc., DJ Ref. No.
90–5–2–1–09567.
The proposed Consent Decree may be
examined at the Office of the United
States Attorney for the District of
Oregon, 1000 SW. Third Avenue, Suite
600, Portland, Oregon 97204–2902, 503–
727–1053, and at the Environmental
Protection Agency, Region 10, 1200 6th
Avenue, Seattle, Washington 98101,
800–424–4372. During the public
comment period, the proposed
Agreement may also be examined on the
following Department of Justice Web
site, https://www.usdoj.gov/enrd/
Consent_Decrees.html. A copy of the
proposed Agreement may also be
obtained by mail from the Consent
Decree Library, P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611 or by faxing or e-mailing a
request to Tonia Fleetwood
(tonia.fleetwood@usdoj.gov), fax no.
(202) 514–0097, phone confirmation
number (202) 514–1547. In requesting a
copy from the Consent Decree Library,
please enclose a check in the amount of
$18.00 (25 cents per page reproduction
cost) payable to the U.S. Treasury.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated February 15, 2011,
and published in the Federal Register
on February 23, 2011, 76 FR 10067,
Sigma Aldrich Manufacturing LLC.,
3500 Dekalb Street, St. Louis, Missouri
63118, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
the following basic classes of controlled
substances:
Robert E. Maher, Jr.,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2011–10052 Filed 4–26–11; 8:45 am]
BILLING CODE 4410–15–P
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
Drug
Schedule
Cathinone (1235) .........................................................................................................................................................................................
Methcathinone (1237) ..................................................................................................................................................................................
Aminorex (1585) ..........................................................................................................................................................................................
Gamma Hydroxybutyric Acid (2010) ...........................................................................................................................................................
Methaqualone (2565) ..................................................................................................................................................................................
Alpha-ethyltryptamine (7249) ......................................................................................................................................................................
Ibogaine (7260) ...........................................................................................................................................................................................
Lysergic acid diethylamide (7315) ...............................................................................................................................................................
Marihuana (7360) ........................................................................................................................................................................................
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
Mescaline (7381) .........................................................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine (7391) ..............................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine (7392) ..........................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine (7395) ..............................................................................................................................................
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................
3,4-Methylenedioxyamphetamine (7400) ....................................................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) ..................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................
3,4-Methylenedioxymethamphetamine (MDMA) (7405) ..............................................................................................................................
4-Methoxyamphetamine (7411) ...................................................................................................................................................................
Bufotenine (7433) ........................................................................................................................................................................................
Diethyltryptamine (7434) .............................................................................................................................................................................
Dimethyltryptamine (7435) ..........................................................................................................................................................................
Psilocybin (7437) .........................................................................................................................................................................................
Psilocyn (7438) ............................................................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ...............................................................................................................................................
N-Benzylpiperazine (BZP) (7493) ...............................................................................................................................................................
Heroin (9200) ...............................................................................................................................................................................................
Normorphine (9313) ....................................................................................................................................................................................
Etonitazene (9624) ......................................................................................................................................................................................
Amphetamine (1100) ...................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
Methylphenidate (1724) ...............................................................................................................................................................................
Amobarbital (2125) ......................................................................................................................................................................................
Pentobarbital (2270) ....................................................................................................................................................................................
Secobarbital (2315) .....................................................................................................................................................................................
Glutethimide (2550) .....................................................................................................................................................................................
Nabilone (7379) ...........................................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
Cocaine (9041) ............................................................................................................................................................................................
Codeine (9050) ............................................................................................................................................................................................
Diprenorphine (9058) ...................................................................................................................................................................................
Oxycodone (9143) .......................................................................................................................................................................................
Hydromorphone (9150) ...............................................................................................................................................................................
Diphenoxylate (9170) ..................................................................................................................................................................................
VerDate Mar<15>2010
15:36 Apr 26, 2011
Jkt 223001
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
E:\FR\FM\27APN1.SGM
27APN1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
]]>Agencies
[Federal Register Volume 76, Number 81 (Wednesday, April 27, 2011)]
[Notices]
[Pages 23625-23626]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-10052]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed Consent Decree Under the Clean Air
Act
Notice is hereby given that on April 13, 2011, a proposed Consent
Decree was filed with the United States District Court for the District
of Oregon in United States v. JELD-WEN, Inc., No. 3:11-cv-453-JT (D.
Or.). The proposed Consent Decree entered into by the United States,
the States of West Virginia, Iowa, and North Carolina, and the company
resolves the United States' and States' claims against the company for
civil penalties and injunctive relief pursuant to the Clean Air Act, 42
U.S.C. 7412, 7413. Under the terms of the Consent Decree, JELD-WEN will
pay the United States and States a combined civil penalty of $850,000,
for excessive emissions of hazardous air pollutants from four door skin
manufacturing plants located in Washington, Iowa, North Carolina, West
Virginia. In addition, JELD-WEN will undertake projects to offset its
excess emission,
[[Page 23626]]
study and install process changes or controls to eliminate excess
emissions, and comply with interim emission limits.
The Department of Justice will receive comments relating to the
proposed Consent Decree for a period of thirty (30) days from the date
of this publication. Comments should be addressed to the Assistant
Attorney General, Environment and Natural Resources Division, and
either e-mailed to pubcomment-ees.enrd@usdoj.gov or mailed to P.O. Box
7611, U.S. Department of Justice, Washington, DC 20044-7611, and should
refer to United States v. JELD-WEN, Inc., DJ Ref. No. 90-5-2-1-09567.
The proposed Consent Decree may be examined at the Office of the
United States Attorney for the District of Oregon, 1000 SW. Third
Avenue, Suite 600, Portland, Oregon 97204-2902, 503-727-1053, and at
the Environmental Protection Agency, Region 10, 1200 6th Avenue,
Seattle, Washington 98101, 800-424-4372. During the public comment
period, the proposed Agreement may also be examined on the following
Department of Justice Web site, https://www.usdoj.gov/enrd/Consent_Decrees.html. A copy of the proposed Agreement may also be obtained by
mail from the Consent Decree Library, P.O. Box 7611, U.S. Department of
Justice, Washington, DC 20044-7611 or by faxing or e-mailing a request
to Tonia Fleetwood (tonia.fleetwood@usdoj.gov), fax no. (202) 514-0097,
phone confirmation number (202) 514-1547. In requesting a copy from the
Consent Decree Library, please enclose a check in the amount of $18.00
(25 cents per page reproduction cost) payable to the U.S. Treasury.
Robert E. Maher, Jr.,
Assistant Section Chief, Environmental Enforcement Section, Environment
and Natural Resources Division.
[FR Doc. 2011-10052 Filed 4-26-11; 8:45 am]
BILLING CODE 4410-15-P
